Bumetanide injection and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 海南卓华制药有限公司
- Publication Date
- 2021-06-04
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medical technology, in particular to a bumetanide injection and a preparation method thereof. Background technique
[0002] Bumetanide is a derivative of m-aminobenzenesulfonamide, which is a powerful diuretic. Clinically, its site of action, mechanism of action and features of action are similar to those of furosemide and ethacrynic acid. It is mainly used for the treatment of liver diseases, Heart failure, kidney disease, etc., with the characteristics of high efficiency, quick action, short action and low toxicity. The diuretic mechanism of bumetanide is related to the inhibition of Na-K-ATPase activity, which is mainly through the inhibition of the thick segment of the ascending branch of the loop of Henle against Cl - Active reabsorption and Na + The passive reabsorption of bumetanide affects the process of concentration and dilution of urine, and plays a diuretic effect. Bumetanide can also act on...